Further enhancing targeted delivery, the same research group of Zhang et al. innovatively introduced CD36-targeted LNs, encapsulating EGCG to enhance targeted delivery to intimal macrophages implicated in atherosclerosis. This evidence concerns the gene CD36 and atherosclerosis.